Extractable Nuclear Antigens and SLE: Specificity and Role in Disease Pathogenesis

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-374994-9.10015-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus.

  2010cited by this paper
• Immunopathology and Infectious Diseases Viral RNA Induces Type I Interferon-Dependent Cytokine Release and Cell Death in Mesangial Cells via Melanoma-Differentiation-Associated Gene-5 Implications for Viral Infection-Associated Glomerulonephritis

  2010cited by this paper
• Factors influencing polyautoimmunity in systemic lupus erythematosus.

  2010cited by this paper
• Complete atrioventricular block as initial manifestation of systemic lupus erythematosus.

  2009cited by this paper
• Pathogenesis of kidney disease in systemic lupus erythematosus

  2009cited by this paper
• High Ro52 expression in spontaneous and UV-induced cutaneous inflammation.

  2009cited by this paper
• Critical Role of TLR2 and TLR4 in Autoantibody Production and Glomerulonephritis in lpr Mutation-Induced Mouse Lupus1

  2009cited by this paper
• RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway.

  2009cited by this paper
• New DNA-sensing pathway feeds RIG-I with RNA

  2009cited by this paper
• Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus

  2009cited by this paper
• Akt phosphorylation of La regulates specific mRNA translation in glial progenitors

  2009cited by this paper
• Latest update on the Ro/SS-A autoantibody system.

  2009cited by this paper
• Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23–Th17 pathway

  2009cited by this paper
• Toll-Like Receptors and Renal Disease

  2009cited by this paper
• RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate

  2009cited by this paper
• Systemic lupus erythematosus in the elderly.

  2008cited by this paper
• Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.

  2008cited by this paper
• Apoptosis-linked changes in the phosphorylation status and subcellular localization of the spliceosomal autoantigen U1-70K

  2008cited by this paper
• Infections as triggers and complications of systemic lupus erythematosus.

  2008cited by this paper
• B cell apotopes of the 60-kDa Ro/SSA and La/SSB autoantigens.

  2008cited by this paper
• Cellular La Protein Shields Nonsegmented Negative-Strand RNA Viral Leader RNA from RIG-I and Enhances Virus Growth by Diverse Mechanisms

  2008cited by this paper
• TRIM family proteins and their emerging roles in innate immunity

  2008cited by this paper
• Lupus nephritis: the central role of nucleosomes revealed.

  2008cited by this paper
• Autoimmune liver disease 2007.

  2008cited by this paper
• The E3 Ubiquitin Ligase Ro52 Negatively Regulates IFN-β Production Post-Pathogen Recognition by Polyubiquitin-Mediated Degradation of IRF31

  2008cited by this paper
• Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).

  2008cited by this paper
• Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus

  2007cited by this paper
• Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference

  2007cited by this paper
• Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus

  2007cited by this paper
• Cutting Edge: Autoantigen Ro52 Is an Interferon Inducible E3 Ligase That Ubiquitinates IRF-8 and Enhances Cytokine Expression in Macrophages1

  2007cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• DAMPs, PAMPs and alarmins: all we need to know about danger

  2007cited by this paper
• TRIM21 is a trimeric protein that binds IgG Fc via the B30.2 domain.

  2007cited by this paper
• Specific combinations of HLA-DR2 and DR3 class II haplotypes contribute graded risk for disease susceptibility and autoantibodies in human SLE

  2007cited by this paper
• Different temporal expression of immunodominant Ro60/60 kDa‐SSA and La/SSB apotopes

  2007cited by this paper
• Antibodies to SS‐A/Ro‐52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis

  2007cited by this paper
• Stress, Heat Shock Proteins, and Autoimmunity

  2007cited by this paper
• Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients

  2007cited by this paper
• Sm antibodies increase risk of death in systemic lupus erythematosus

  2007cited by this paper
• Comparison of Three Multiplex Immunoassays for Detection of Antibodies to Extractable Nuclear Antibodies Using Clinically Defined Sera

  2007cited by this paper
• Review: Congenital heart block: clinical features and therapeutic approaches

  2007cited by this paper
• Anti-dsDNA and anti-Sm antibodies do not predict damage in systemic lupus erythematosus

  2006cited by this paper
• Familial aggregation and linkage analysis of autoantibody traits in pedigrees multiplex for systemic lupus erythematosus

  2006cited by this paper
• A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus

  2006cited by this paper
• An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus.

  2006cited by this paper
• Post‐translational modifications of the major linear epitope 169–190aa of Ro60 kDa autoantigen alter the autoantibody binding

  2006cited by this paper
• Mixed connective tissue disease

  2006cited by this paper
• Ro52, Ro60 and La IgG autoantibody levels and Ro52 IgG subclass profiles longitudinally throughout pregnancy in congenital heart block risk pregnancies

  2006cited by this paper
• A murine model of mixed connective tissue disease induced with U1 small nuclear RNP autoantigen.

  2006cited by this paper
• Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus.

  2006cited by this paper
• From ANA to ENA: how to proceed?

  2006cited by this paper
• Neo‐epitopes are required for immunogenicity of the La/SS‐B nuclear antigen in the context of late apoptotic cells

  2006cited by this paper
• The curiously suspicious: a role for Epstein-Barr virus in lupus

  2006cited by this paper
• The Ro 60 kDa autoantigen comes into focus: interpreting epitope mapping experiments on the basis of structure.

  2006cited by this paper
• Phosphorylated and nonphosphorylated epitopes of the La/SSB autoantigen: comparison of their antigenic and conformational characteristics.

  2006cited by this paper
• Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual.

  2006cited by this paper
• The Epstein-Barr Virus-Encoded LMP-1 Oncoprotein Negatively Affects Tyk2 Phosphorylation and Interferon Signaling in Human B Cells

  2006cited by this paper
• Anti-Sm and anti-RNP antibodies

  2005cited by this paper
• Anti-Ro/SSA and La/SSB antibodies

  2005cited by this paper
• Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.

  2005cited by this paper
• 52-kDa Ro/SSA epitopes preferentially recognized by antibodies from mothers of children with neonatal lupus and congenital heart block

  2005cited by this paper
• Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry

  2005cited by this paper
• Structurally Derived Mutations Define Congenital Heart Block‐Related Epitopes Within the 200–239 Amino Acid Stretch of the Ro52 Protein

  2005cited by this paper
• Regulation of the Transcriptional Activity of the IRF7 Promoter by a Pathway Independent of Interferon Signaling*

  2005cited by this paper
• Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication.

  2005cited by this paper
• Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus.

  2005cited by this paper
• Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?

  2005cited by this paper
• Detection and identification of significant ANAs in previously determined ANA negative samples.

  2005cited by this paper
• Human La is found at RNA polymerase III-transcribed genes in vivo.

  2005cited by this paper
• Antinuclear autoantibodies in systemic lupus erythematosus

  2004cited by this paper
• CK2 Is Responsible for Phosphorylation of Human La Protein Serine-366 and Can Modulate rpL37 5′-Terminal Oligopyrimidine mRNA Metabolism

  2004cited by this paper
• La Autoantigen Is Necessary for Optimal Function of the Poliovirus and Hepatitis C Virus Internal Ribosome Entry Site In Vivo and In Vitro

  2004cited by this paper
• Epstein–Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway

  2004cited by this paper
• Detection of anti-SSA antibodies by indirect immunofluorescence.

  2004cited by this paper
• Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies.

  2004cited by this paper
• Enrichment of Anti-Glomerular Antigen Antibody-Producing Cells in the Kidneys of MRL/MpJ-Faslpr Mice1

  2004cited by this paper
• Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.

  2004cited by this paper
• Cardiac involvement in patients with systemic lupus erythematosus and correlation of valvular lesions with anti-Ro/SS-A and anti-La/SS-B antibody levels

  2004cited by this paper
• Infectious mononucleosis patients temporarily recognize a unique, cross‐reactive epitope of Epstein‐Barr virus nuclear antigen‐1

  2003cited by this paper
• Association of stress proteins with autoantigens: a possible mechanism for triggering autoimmunity?

  2003cited by this paper
• Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations.

  2003cited by this paper
• A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen

  2003cited by this paper
• Development of autoantibodies before the clinical onset of systemic lupus erythematosus.

  2003cited by this paper
• Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus.

  2003cited by this paper
• Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis

  2003cited by this paper
• Interferon Regulatory Factor 7 Regulates Expression of Epstein-Barr Virus Latent Membrane Protein 1: a Regulatory Circuit

  2003cited by this paper
• Epitope spreading in immune-mediated diseases: implications for immunotherapy

  2002cited by this paper
• Oxidative stress mediates cell surface expression of SS-A/Ro antigen on keratinocytes.

  2002cited by this paper
• Subcellular Redistribution and Surface Exposure of the Ro52, Ro60 and La48 Autoantigens During Apoptosis in Human Ductal Epithelial Cells: a Possible Mechanism in the Pathogenesis of Sjögren's Syndrome

  2002cited by this paper
• Epstein–Barr virus RNA confers resistance to interferon‐α‐induced apoptosis in Burkitt's lymphoma

  2002cited by this paper
• The Danger Model: A Renewed Sense of Self

  2002cited by this paper
• Pathogenetic associations of maternal Anti-Ro/SSA antibodies

  2002cited by this paper
• Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions.

  2001cited by this paper
• Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women.

  2001cited by this paper
• Development of Anti‐dsDNA Autoantibodies Prior to Clinical Diagnosis of Systemic Lupus Erythematosus

  2001cited by this paper
• Anti-calreticulin segregates anti-Ro sera in systemic lupus erythematosus: anti-calreticulin is present in sera with anti-Ro alone but not in anti-Ro sera with anti-La or anti-ribonucleoprotein.

  2000cited by this paper
• Rapid lupus autoantigen relocalization and reactive oxygen species accumulation following ultraviolet irradiation of human keratinocytes.

  2000cited by this paper
• Anti‐SSA/Ro52 autoantibodies blocking the cardiac 5‐HT4 serotoninergic receptor could explain neonatal lupus congenital heart block

  2000cited by this paper
• Comparison of the Anti-Ro/SSA Autoantibody Profile between Patients with Primary and Secondary Sjogren's Syndrome

  2000cited by this paper
• La Autoantigen Is Cleaved in the COOH Terminus and Loses the Nuclear Localization Signal during Apoptosis*

  2000cited by this paper

• Long‐Term Outcomes of Children Born to Anti‐Ro Antibody–Positive Mothers With and Without Rheumatic Disease

  2025cites this paper
• Monitoring of Women with Anti-Ro/SSA and Anti-La/SSB Antibodies in Germany—Status Quo and Intensified Monitoring Concepts

  2024cites this paper
• Passively acquired lupus in the fetus and neonate

  2021cites this paper
• Neonatal lupus: Clinical spectrum, biomarkers, pathogenesis, and approach to treatment

  2021cites this paper
• Is There Any Correlation between Anti-Ro 52 Antibody Level with Hematological Abnormalities in Systemic Lupus Erythematosus?

  2021cites this paper
• Autoimmune-mediated congenital heart block.

  2020cites this paper
• A review of fetal and neonatal consequences of maternal systemic lupus erythematosus

  2020cites this paper
• Diagnostic dilemma and Management challenges of Neonatal Lupus with Complete Congenital Heart Block in a resource poor set-up – A case report

  2020cites this paper
• The complement receptor 3 (CD11b/CD18) agonist Leukadherin‐1 suppresses human innate inflammatory signalling

  2016cites this paper
• Neonatal lupus: Clinical spectrum, biomarkers, pathogenesis, and approach to treatment

  2016cites this paper